| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.4M | -22.2% |
| SG&A Expense | $5.5M | +77.7% |
| Operating Income | -$10.9M | +9.1% |
| Income Tax | $0 | — |
| Net Income | -$10.8M | -408.3% |
| EPS (Basic) | -$20.09 | -1617.1% |
| EPS (Diluted) | -$20.09 | +52.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | +6589.0% |
| Current Assets | $5.4M | +6393.4% |
| Total Assets | $5.5M | -88.6% |
| Current Liabilities | $4.5M | -18.9% |
| Total Liabilities | $4.5M | -47.0% |
| Stockholders' Equity | $1.1M | +113.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -1446.2% |
| Capital Expenditures | $132K | +0.0% |
| Investing Cash Flow | -$132K | -100.5% |
| Financing Cash Flow | $15.2M | +160.9% |
| Free Cash Flow | -$11.4M | -1223.6% |